Join to View Full Profile
6000 W Creek RdSte 10Independence, OH 44131
Phone+1 216-831-0120
Fax+1 216-445-2226
Dr. Sood-Mendiratta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Shalini Sood-Mendiratta is an ophthalmologist in Cleveland, OH and is affiliated with Cleveland Clinic. She received her medical degree from Albany Medical College and has been in practice 15 years. She specializes in cataract related and glaucoma related and is experienced in glaucoma and related disorders, glaucoma surgery, and general / comprehensive ophthalmology.
Education & Training
University of Illinois College of Medicine at ChicagoResidency, Ophthalmology, 2003 - 2006
Advocate Illinois Masonic Medical CenterInternship, Transitional Year, 2002 - 2003
Albany Medical CollegeClass of 2002
Certifications & Licensure
OH State Medical License 2011 - 2028
SC State Medical License 2009 - 2013
IL State Medical License 2002 - 2011
GA State Medical License 2006 - 2007
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017
Publications & Presentations
PubMed
- Home Tonometry Diurnal Intraocular Pressure Patterns, Patient Adherence, and Measurement Reliability in a Prospective Clinical Cohort.Scott W Perkins, Julia H Joo, Kevin C Allan, Shalini Sood, Matthew James Schulgit
Clinical Ophthalmology. 2025-01-01 - 19 citationsExperience with netarsudil 0.02% and latanoprostene bunod 0.024% as adjunctive therapy for glaucoma.Amy A. Mehta, Levi N. Kanu, Shalini Sood-Mendiratta, Richard Quinones, Anjali S Hawkins
European Journal of Ophthalmology. 2021-03-02 - 14 citationsLong-term Clinical Outcomes of Pars Plana Versus Anterior Chamber Placement of Glaucoma Implant Tubes.Vivian L. Qin, Mona Kaleem, Felipe F Conti, Edward J. Rockwood, Annapurna Singh
Journal of Glaucoma. 2018-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
